U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research | CDER
  5. Division of Oncology 2 (DO2)
  1. Center for Drug Evaluation and Research | CDER

Division of Oncology 2 (DO2)

The Division of Oncology 2 (DO2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas: Thoracic Head & neck, Neuro-oncology Rare cancers, Pediatric solid tumors.

Management Team

Division Director (Acting), Harpreet Singh, MD
Deputy Director: Vacant

Office of Regulatory Operations – Oncologic Diseases (ORO-OD) for DO2

Chief Project Management Staff: Melanie Pierce (Acting)

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology 2 (DO2)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-2320
Fax: (301) 796-9849

Resources For You

Back to Top